ANI Pharmaceuticals Inc
NASDAQ:ANIP

Watchlist Manager
ANI Pharmaceuticals Inc Logo
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Watchlist
Price: 58.91 USD -1.54% Market Closed
Market Cap: 1.2B USD
Have any thoughts about
ANI Pharmaceuticals Inc?
Write Note

ANI Pharmaceuticals Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ANI Pharmaceuticals Inc
Capital Expenditures Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Capital Expenditures
-$13m
CAGR 3-Years
-33%
CAGR 5-Years
-18%
CAGR 10-Years
-41%
Johnson & Johnson
NYSE:JNJ
Capital Expenditures
-$4.4B
CAGR 3-Years
-7%
CAGR 5-Years
-4%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Capital Expenditures
-$1.2B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
-8%
Pfizer Inc
NYSE:PFE
Capital Expenditures
-$3.2B
CAGR 3-Years
-2%
CAGR 5-Years
-4%
CAGR 10-Years
-7%
Merck & Co Inc
NYSE:MRK
Capital Expenditures
-$3.4B
CAGR 3-Years
10%
CAGR 5-Years
-1%
CAGR 10-Years
-11%
Eli Lilly and Co
NYSE:LLY
Capital Expenditures
-$8.3B
CAGR 3-Years
-53%
CAGR 5-Years
-38%
CAGR 10-Years
-18%

See Also

What is ANI Pharmaceuticals Inc's Capital Expenditures?
Capital Expenditures
-13m USD

Based on the financial report for Jun 30, 2024, ANI Pharmaceuticals Inc's Capital Expenditures amounts to -13m USD.

What is ANI Pharmaceuticals Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-41%

Over the last year, the Capital Expenditures growth was -25%. The average annual Capital Expenditures growth rates for ANI Pharmaceuticals Inc have been -33% over the past three years , -18% over the past five years , and -41% over the past ten years .

Back to Top